- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 25.08. | Ortivus AB Ser. B Q2 Loss Decreases | 1 | RTTNews | ||
| 25.08. | Ortivus AB: Interim Report for Ortivus AB (publ) for the period April - June 2026 | 134 | GlobeNewswire (Europe) | "Ortivus' deep domain knowledge and advancements in AI mean that we, with the MobiMed platform, are well positioned to meet the healthcare sector's urgent need for increased efficiency."
April-June... ► Artikel lesen | |
| 07.05. | Ortivus AB: Interim Report for Ortivus AB (publ) for the period January-March 2026 | 224 | GlobeNewswire (Europe) | "We are fully embracing AI, both in our products and in our internal operations."
January-March 2026 Net sales increased with 18% and amounted to SEK 21.5 (18.1) million.The gross margin increased to... ► Artikel lesen | |
| 04.05. | Ortivus AB: Ortivus AB completes sale of its holding in H&E Solutions AB and realises a profit | 211 | GlobeNewswire (Europe) | Ortivus AB today announces that it has completed the sale of its entire shareholding in the technology company H&E Solutions AB (Evam) for a purchase price of SEK 5.2 million. The transaction results... ► Artikel lesen | |
| 21.04. | Ortivus AB: Ortivus AB welcomes Matti Zemack as new Chief Product Officer | 316 | GlobeNewswire (Europe) | Ortivus is pleased to announce the appointment of Matti Zemack as the new Chief Product Officer (CPO). In this strategic role, Zemack will lead the company's product vision and development, driving... ► Artikel lesen | |
| 31.03. | Ortivus AB: Ortivus strengthens liquidity to accelerate the company's growth strategy | 202 | GlobeNewswire (Europe) | Ortivus is enabling increased investment in its growth strategy by further strengthening its financial position with an additional loan of SEK 5 million, following the full utilisation of the SEK 20... ► Artikel lesen | |
| 19.02. | Ortivus AB: Year-end Report January - December 2025 | 318 | GlobeNewswire (Europe) | "We enter 2026 with a strengthened balance sheet, a more efficient organisation, and a portfolio of innovations already making a difference."
October-December 2025Net sales decreased by 12% and amounted... ► Artikel lesen | |
| ORTIVUS Aktie jetzt für 0€ handeln | |||||
| 13.01. | The observation status for Ortivus AB is removed | 472 | GlobeNewswire | On December 2, 2025, the shares in Ortivus AB (the "Company") were given observation status with reference to a mandatory public offer from Ponderus Invest AB to the other shareholders in Ortivus... ► Artikel lesen | |
| 13.01. | Ortivus AB: Ortivus informs that Ponderus Invest AB has announced the final outcome of the mandatory cash offer to the shareholders of Ortivus Aktiebolag | 268 | GlobeNewswire (Europe) | Ponderus Invest AB ("Ponderus") announced on 2 December 2025 a mandatory cash offer to the shareholders of Ortivus Aktiebolag ("Ortivus" or the "Company") to transfer all of their shares in Ortivus... ► Artikel lesen | |
| 22.12.25 | Ortivus AB: Ortivus informs that Ponderus Invest AB has announced approval from the Swedish Inspectorate of Strategic Products regarding the mandatory cash offer to the shareholders of Ortivus Aktiebolag | 227 | GlobeNewswire (Europe) | Ponderus Invest AB ("Ponderus") announced on 2 December 2025 a mandatory cash offer to the shareholders of Ortivus Aktiebolag ("Ortivus") to transfer all of their shares in Ortivus to Ponderus for SEK... ► Artikel lesen | |
| 18.12.25 | Ortivus AB: The independent bid committee of Ortivus unanimously recommends that shareholders do not accept the mandatory cash offer submitted by Ponderus Invest AB | 315 | GlobeNewswire (Europe) | The independent bid committee of Ortivus AB (publ) ("Ortivus" or the "Company") unanimously recommends that shareholders of Ortivus do not accept the mandatory cash offer submitted by Ponderus Invest... ► Artikel lesen | |
| 17.12.25 | Ortivus AB: Ortivus welcomes Minni Raij as new CFO | 276 | GlobeNewswire (Europe) | Ortivus is pleased to announce the appointment of Minni Raij as the new Chief Financial Officer (CFO) at Ortivus. Minni brings more than two decades of experience in finance and management. Minni will... ► Artikel lesen | |
| 02.12.25 | Ortivus AB receives observation status | 222 | GlobeNewswire | Today, December 2, 2025, Ponderus Invest AB disclosed a mandatory public offer to the other shareholders in Ortivus AB.
The rules of Nasdaq First North Growth Market state that an issuer may... ► Artikel lesen | |
| 02.12.25 | Ortivus AB: Ortivus announces mandatory public offer from Ponderus Invest AB | 214 | GlobeNewswire (Europe) | On 14 November 2025, Ponderus Invest AB announced its intention to return no later than 3 December 2025 with information regarding a potential mandatory public offer to the shareholders of Ortivus AB... ► Artikel lesen | |
| 28.11.25 | Ortivus AB: Interim Report for Ortivus AB (publ) for the period July - September 2025 | 350 | GlobeNewswire (Europe) | "The increased interest we are witnessing in the market and from existing customers, together with the high pace of our product development, gives us a positive outlook for the future."
July-September... ► Artikel lesen | |
| 14.11.25 | Ortivus AB: Ortivus Informs About A Possible Mandatory Bid From Ponderus Invest | 230 | GlobeNewswire (Europe) | Ortivus Aktiebolag ("Ortivus" or the "Company") resolved at an extraordinary general meeting on September 19, 2025 to carry out a fully guaranteed rights issue of B shares corresponding to an issue... ► Artikel lesen | |
| 15.10.25 | Ortivus AB: Ortivus announces that CFO Johan Wewel has decided to leave his position | 229 | GlobeNewswire (Europe) | Ortivus announces today that the company's CFO, Johan Wewel, has decided to leave his position to take up a role outside the Group. Johan Wewel will remain in his current position until 7 January 2026... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 43,635 | -0,38 % | Fresenius Kabi erhält Warnung von der US-Gesundheitsbehörde FDA | DJ Fresenius Kabi erhält Warnung von der US-Gesundheitsbehörde FDA
DOW JONES--Die Fresenius-Tochter Kabi hat einen Warnschuss von der US-Gesundheitsbehörde FDA erhalten. In dem am Dienstag veröffentlichten... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 37,860 | +0,66 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers mit einem Kursziel von 50 Euro auf "Buy" belassen. Accela sei ein Quantensprung in der Strahlentherapie... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,550 | -0,33 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 11,830 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 60,27 | +0,03 % | BMO Capital reiterates Outperform on BrightSpring Health stock | ||
| BILLIONTOONE | 105,90 | 0,00 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| HEARTFLOW | 49,270 | -0,10 % | AI Cardiac Diagnostics Pioneer Sets HeartFlow (HTFL) for High-Margin Expansion | ||
| PROCEPT BIOROBOTICS | 17,160 | 0,00 % | PROCEPT BioRobotics Corp - 8-K, Current Report | ||
| ALIGNMENT HEALTHCARE | 7,945 | 0,00 % | Are Options Traders Betting on a Big Move in Alignment Healthcare Stock? | ||
| CARL ZEISS MEDITEC | 31,300 | +0,32 % | Carl Zeiss Meditec: Das Chartbild sieht spannend aus, aber … | Nachdem Carl Zeiss Meditec im Januar eine Gewinnwarnung veröffentlichte und einbrach, gelang zwar eine Bodenbildung, aber zurück in den Fokus der Käufer gelangte die Aktie nicht mehr. Doch jetzt sieht... ► Artikel lesen | |
| QTREX QUANTUM | 1,100 | 0,00 % | Qtrex Quantum jumps 40% | ||
| GENEDX | 73,03 | -0,08 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| AVEANNA HEALTHCARE | 12,590 | 0,00 % | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | ||
| PROGYNY | 25,220 | 0,00 % | Progyny vor dem Boom?: Wells Fargo sieht bei dieser "Kinderwunsch-Aktie" 42 % Kurspotenzial | © Foto: SOPA Images - Sipa USAWells Fargo traut Progyny 42 Prozent Kurspotenzial zu. Das Geschäft mit Kinderwunsch-Leistungen könnte jetzt zum großen Wachstumstreiber werden Enthaltene Werte: US74340E1038Den... ► Artikel lesen | |
| SANARA MEDTECH | 34,860 | +0,03 % | Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) | FORT WORTH, TX, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," "Sanara MedTech," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology company focused on developing... ► Artikel lesen |
Das Unternehmen ORTIVUS AB kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ORTIVUS AB finden Sie auf Wallstreet Online.